Thalidomide	NNP	thalidomide NN PennPOS
reduces	VBZ	reduce VBZ PennPOS
IL-18	NN	IL-18 NN PennPOS
,	,	, , NUPOS
IL-8	NN	IL-8 NN PennPOS
and	CC	and cc NUPOS
TNF-alpha	NN	TNF-alpha NN PennPOS
release	NN	release NN PennPOS
from	IN	from pp NUPOS
alveolar	JJ	alveolar JJ PennPOS
macrophages	NNS	macrophage NNS PennPOS
in	IN	in IN PennPOS
interstitial	JJ	interstitial JJ PennPOS
lung	NN	lung NN PennPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

Thalidomide	NN	thalidomide NN PennPOS
exhibits	VBZ	exhibit VBZ PennPOS
diverse	JJ	diverse JJ PennPOS
actions	NNS	action NNS PennPOS
of	IN	of pp-f NUPOS
anti-inflammation	JJ	anti-inflammation JJ PennPOS
,	,	, , NUPOS
immunomodulation	NN	immunomodulation NN PennPOS
and	CC	and cc NUPOS
anti-angiogenesis	NN	anti-angiogenesis NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
efficacy	NN	efficacy NN PennPOS
of	IN	of pp-f NUPOS
thalidomide	NN	thalidomide NN PennPOS
treatment	NN	treatment NN PennPOS
in	IN	in IN PennPOS
sarcoidosis	NN	sarcoidosis NN PennPOS
with	IN	with pp NUPOS
lupus	NN	lupus NN PennPOS
pernio	NN	pernio NN PennPOS
is	VBZ	be vbz NUPOS
thought	VBN	think VBN PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
due	JJ	due JJ PennPOS
to	TO	to p-acp NUPOS
inhibition	NN	inhibition NN PennPOS
of	IN	of pp-f NUPOS
tumour	NN	tumour NN PennPOS
necrosis	NN	necrosis NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
TNF	NN	TNF NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
alpha	NN	alpha NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
mechanisms	NNS	mechanism NNS PennPOS
that	WDT	that WDT PennPOS
underlie	VBP	underlie VBP PennPOS
the	DT	the dt NUPOS
properties	NNS	property NNS PennPOS
of	IN	of pp-f NUPOS
thalidomide	NN	thalidomide NN PennPOS
are	VBP	be vbb NUPOS
still	RB	still av NUPOS
unclear	JJ	unclear JJ PennPOS
in	IN	in IN PennPOS
interstitial	JJ	interstitial JJ PennPOS
lung	NN	lung NN PennPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
current	JJ	current JJ PennPOS
authors	NNS	author NNS PennPOS
investigated	VBD	investigate VBD PennPOS
the	DT	the dt NUPOS
potential	JJ	potential JJ PennPOS
inhibitory	JJ	inhibitory JJ PennPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
thalidomide	NN	thalidomide NN PennPOS
at	IN	at pp NUPOS
concentrations	NNS	concentration NNS PennPOS
of	IN	of pp-f NUPOS
0.1	CD	0.1 CD PennPOS
,	,	, , NUPOS
0.01	CD	0.01 CD PennPOS
and	CC	and cc NUPOS
0.001	CD	0.001 CD PennPOS
mM	NN	mm NN PennPOS
on	IN	on IN PennPOS
the	DT	the dt NUPOS
production	NN	production NN PennPOS
of	IN	of pp-f NUPOS
transforming-growth-factor-beta	NN	transforming-growth-factor-beta NN PennPOS
,	,	, , NUPOS
TNF-alpha	NN	TNF-alpha NN PennPOS
,	,	, , NUPOS
interleukin	NN	interleukin NN PennPOS
(	(	( ( NUPOS
IL	NN	IL NN PennPOS
)	)	) ) NUPOS
-1	CD	-1 CD PennPOS
beta	NN	beta NN PennPOS
,	,	, , NUPOS
IL-6	NN	IL-6 NN PennPOS
,	,	, , NUPOS
IL-8	NN	IL-8 NN PennPOS
,	,	, , NUPOS
IL-10	NN	IL-10 NN PennPOS
,	,	, , NUPOS
IL-12p70	NN	IL-12p70 NN PennPOS
,	,	, , NUPOS
IL-12p40	NN	IL-12p40 NN PennPOS
and	CC	and cc NUPOS
IL-18	NN	IL-18 NN PennPOS
by	IN	by IN PennPOS
alveolar	JJ	alveolar JJ PennPOS
macrophages	NNS	macrophage NNS PennPOS
from	IN	from pp NUPOS
bronchoalveolar	JJ	bronchoalveolar JJ PennPOS
lavage	NN	lavage NN PennPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
sarcoidosis	NN	sarcoidosis NN PennPOS
(	(	( ( NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
8	CD	8 crd NUPOS
)	)	) ) NUPOS
,	,	, , NUPOS
hypersensitivity	NN	hypersensitivity NN PennPOS
pneumonitis	NN	pneumonitis NN PennPOS
(	(	( ( NUPOS
HP	NNP	hp NN PennPOS
;	:	; : NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
8	CD	8 crd NUPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
;	:	; : NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
12	CD	12 crd NUPOS
)	)	) ) NUPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
sarcoidosis	NN	sarcoidosis NN PennPOS
and	CC	and cc NUPOS
HP	NNP	hp NN PennPOS
patients	NNS	patient NNS PennPOS
,	,	, , NUPOS
thalidomide	NN	thalidomide NN PennPOS
induced	VBD	induce VBD PennPOS
a	DT	a dt NUPOS
dose-dependent	JJ	dose-dependent JJ PennPOS
,	,	, , NUPOS
partial	JJ	partial JJ PennPOS
suppression	NN	suppression NN PennPOS
of	IN	of pp-f NUPOS
lipopolysacchride	NN	lipopolysacchride NN PennPOS
(	(	( ( NUPOS
LPS	NN	LPS NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
stimulated	VBN	stimulate VBN PennPOS
TNF-alpha	NN	TNF-alpha NN PennPOS
,	,	, , NUPOS
IL-12p40	NN	IL-12p40 NN PennPOS
and	CC	and cc NUPOS
IL-18	NN	IL-18 NN PennPOS
release	NN	release NN PennPOS
.	.	. . NUPOS

At	IN	at pp NUPOS
the	DT	the dt NUPOS
highest	JJS	high JJS PennPOS
thalidomide	NN	thalidomide NN PennPOS
concentration	NN	concentration NN PennPOS
(	(	( ( NUPOS
0.1	CD	0.1 CD PennPOS
mM	NN	mm NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
LPS-stimulated	JJ	lps-stimulated JJ PennPOS
IL-8	NN	IL-8 NN PennPOS
production	NN	production NN PennPOS
was	VBD	be vbd NUPOS
also	RB	also av NUPOS
suppressed	VBN	suppress VBN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
,	,	, , NUPOS
although	IN	although cs NUPOS
spontaneous	JJ	spontaneous JJ PennPOS
production	NN	production NN PennPOS
of	IN	of pp-f NUPOS
TNF-alpha	NN	TNF-alpha NN PennPOS
,	,	, , NUPOS
IL-12p40	NN	IL-12p40 NN PennPOS
,	,	, , NUPOS
IL-18	NN	IL-18 NN PennPOS
and	CC	and cc NUPOS
IL-8	NN	IL-8 NN PennPOS
was	VBD	be vbd NUPOS
lower	JJR	low JJR PennPOS
than	IN	than cs NUPOS
in	IN	in IN PennPOS
sarcoidosis	NN	sarcoidosis NN PennPOS
and	CC	and cc NUPOS
HP	NNP	hp NN PennPOS
patients	NNS	patient NNS PennPOS
,	,	, , NUPOS
with	IN	with pp NUPOS
LPS	NN	LPS NN PennPOS
stimulation	NN	stimulation NN PennPOS
the	DT	the dt NUPOS
cytokines	NNS	cytokine NNS PennPOS
were	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
elevated	JJ	elevated JJ PennPOS
and	CC	and cc NUPOS
also	RB	also av NUPOS
partially	RB	partial av-j NUPOS
inhibited	VBN	inhibit VBN PennPOS
by	IN	by IN PennPOS
thalidomide	NN	thalidomide NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
conclusion	NN	conclusion NN PennPOS
,	,	, , NUPOS
thalidomide	NN	thalidomide NN PennPOS
has	VBZ	have vdz NUPOS
the	DT	the dt NUPOS
potential	JJ	potential JJ PennPOS
to	TO	to p-acp NUPOS
improve	VB	improve VBP PennPOS
the	DT	the dt NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
regimens	NNS	regimen NNS PennPOS
for	IN	for c-acp NUPOS
sarcoidosis	NN	sarcoidosis NN PennPOS
,	,	, , NUPOS
hypersensitivity	NN	hypersensitivity NN PennPOS
pneumonitis	NN	pneumonitis NN PennPOS
and	CC	and cc NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
by	IN	by IN PennPOS
reducing	VBG	reduce VBG PennPOS
tumour	NN	tumour NN PennPOS
necrosis	NN	necrosis NN PennPOS
factor-alpha	NN	factor-alpha NN PennPOS
,	,	, , NUPOS
interleukin-12p40	NN	interleukin-12p40 NN PennPOS
,	,	, , NUPOS
interleukin-18	NN	interleukin-18 NN PennPOS
and	CC	and cc NUPOS
interleukin-8	NN	interleukin-8 NN PennPOS
production	NN	production NN PennPOS
.	.	. . NUPOS

